6 results
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
#INR #heparin #LMWH ... #NOAC #warfarin ... Xarelto #apixaban #Eliquis ... #dabigatran #Pradaxa
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Kcentra) - Heparin/LMWH ... Protamine sulfate - Dabigatran ... ) - Apixaban (Eliquis ... anticoagulation #doac ... #noac #pharmacology
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Weight Heparin (LMWH ... ) inhibitors - Dabigatran ... #medications #doac
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
(e.g. heparin, LMWH ... weight heparin (LMWH ... Pathophysiology #Heparins #LMWH ... #UFH #DOAC #Dabigatran ... #Fondaparinux #NOAC
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
initiated after a LMWH ... ¥LMWH is currently ... DOAC, direct oral ... anticoagulant; LMWH ... #DOAC #VTE #Malignancy
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... filtration rate; DOAC ... anticoagulant; LMWH ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm